Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-31 Sale | 2024-11-04 4:05 pm | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 5,000 | $54.14 | $270,715 | 33,348 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 4:36 pm | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $44 | $94,820 | 52,438 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:01 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 20,194 | $6.47 | $130,655 | 212,014 (Direct) | View |
| 2024-04-10 Sale | 2024-04-12 4:23 pm | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $37 | $79,735 | 50,345 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:00 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer | 5,698 | $24.04 | $137,008 | 148,873 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:36 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer | 15,575 | $18.05 | $281,129 | 154,571 (Direct) | View |
| 2022-05-16 Sale | 2022-05-18 7:01 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Commercial Officer | 10,687 | $14.59 | $155,923 | 130,146 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Exercise | 2024-11-04 4:05 pm | 2024-06-08 2033-06-07 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 5,000 | $0 | 33,348 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 4:05 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 5,000 | $24.84 | 33,348 (Direct) | View |
| 2024-07-09 Exercise | 2024-07-10 4:36 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $16.8 | 52,438 (Direct) | View |
| 2024-07-09 Exercise | 2024-07-10 4:36 pm | N/A 2032-06-15 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $0 | 52,438 (Direct) | View |
| 2024-06-20 Option Award(A) | 2024-06-28 5:06 pm | N/A 2034-06-19 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 20,203 | $0 | 35,903 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 4:22 pm | N/A 2034-06-19 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 21,500 | $0 | 37,200 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 4:23 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $16.8 | 50,345 (Direct) | View |
| 2024-04-10 Exercise | 2024-04-12 4:23 pm | N/A 2032-06-15 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,155 | $0 | 50,345 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:03 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 333,335 | $0 | 482,208 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:14 pm | N/A 2033-06-07 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 23,600 | $0 | 34,100 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:01 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Strategy Officer | 100,000 | $0 | 230,146 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:06 pm | N/A 2032-06-15 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 47,300 | $0 | 47,300 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:16 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Commercial Officer | 131,250 | $0 | 219,583 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 9:02 pm | N/A 2031-05-03 | Replimune Group Inc. | REPL | Patel Sushil Chief Commercial Officer | 213,333 | $0 | 213,333 (Direct) | View |